RGNTRegentis Biomaterials Ltd. Ordinary Shares
2.230USD+9.31%Mkt Cap: 15.66M $P/E:

Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacryla…

HeadlineSourceTime
Older
This Monthly Dividend Powerhouse Is Trading at a Bargain-Bin Valuation

EPR Properties offers income investors a rare combination: a 6.3% monthly dividend yield, a conservative 73% payout ratio, and diversified exposure to experiential real estate well beyond movie theatres, trading at just 10.7x FFO.

Barchart
Why Did RGNT Stock Surge More Than 850% Today?

Regentis Biomaterials filed a notice to withdraw its Form F-1 registration statement, indicating that it did not wish to proceed with a proposed public offering announced last month.

Stocktwits
Regentis Biomaterials (RGNT) Appoints New CFO/CBO as GelrinC Nears Commercial Launch

Regentis Biomaterials Ltd. (NYSEAMERICAN:RGNT) is one of the best up and coming penny stocks to buy. On February 4, Regentis Biomaterials appointed Ori Gon as Chief Financial Officer and Chief Business Officer to lead the company’s financial strategy and commercial development. Gon joined the regenerative medicine firm as its lead product, GelrinC, nears commercial launch […]

IInsider Monkey
Sector Update: Health Care Stocks Slide Late Afternoon

Health care stocks declined late Thursday afternoon, with the NYSE Health Care Index and the Health

MMT Newswires
Sector Update: Health Care Stocks Softer in Afternoon Trading

Health care stocks declined Thursday afternoon with the NYSE Health Care Index dropping 0.5% and the

MMT Newswires